🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMy fatty liver reversal — November 2025 Page 3

My fatty liver reversal — November 2025

rachel_ABQ Mon, Dec 15, 2025 at 11:22 AM 33 replies 1,345 viewsPage 3 of 7
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Dec 20, 2025 at 10:04 AM#11
pat_auckland said:
Start from the measurement rather than the conclusion.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

Happy to go further on any of that.

48 21CryptoCarl, MariaRD, AussieAnna and 45 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Dec 20, 2025 at 2:33 PM#12
LondonLisa said:
Liver enzyme update related to liver and MASH: I had mildly elevated ALT/AST at baseline (likely NAFLD).

That reframing is the part I needed. I will report back once I have actually tried it.

Last edited: Dec 20, 2025 at 8:33 PM
49 22TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 46 others
Reply Quote Save Share Report
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
Dec 20, 2025 at 7:02 PM#13
pat_auckland said:
Start from the measurement rather than the conclusion.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

50 23JenMemphis, pat_auckland, Dr.GastroMayo and 47 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Dec 20, 2025 at 11:31 PM#14

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

1 24james_edin
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 21, 2025 at 4:00 AM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

2 0PeptideSynthNJ, Dr.KarenChen
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register